APO Research
Talk to an analyst

APO RESEARCH · REPORT

Chronic Urticaria Or Hives Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Chronic Urticaria Or Hives Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025190 pages

Choose your research edition.

Industry ResearchChronic Urticaria Or Hives Drug Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Chronic Urticaria Or Hives Drug Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Chronic Urticaria Or Hives Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chronic Urticaria Or Hives Drug Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Chronic Urticaria Or Hives Drug Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Chronic Urticaria Or Hives Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Chronic Urticaria Or Hives Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Chronic Urticaria Or Hives Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Chronic Urticaria Or Hives Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Chronic Urticaria Or Hives Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Chronic Urticaria Or Hives Drug include Novartis AG, Merck & Co., Inc., AstraZeneca Plc, Panacea Biotec Limited, Mycenax Biotech Inc., Mabtech Limited, J Uriach Y Compania, S.A., GlaxoSmithKline Plc and Genentech, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Chronic Urticaria Or Hives Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Chronic Urticaria Or Hives Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Chronic Urticaria Or Hives Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Chronic Urticaria Or Hives Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Chronic Urticaria Or Hives Drug Segment by Company

Novartis AG

Merck & Co., Inc.

AstraZeneca Plc

Panacea Biotec Limited

Mycenax Biotech Inc.

Mabtech Limited

J Uriach Y Compania, S.A.

GlaxoSmithKline Plc

Genentech, Inc.

Faes Farma, SA

ELORAC, Inc.

Biofrontera AG

Chronic Urticaria Or Hives Drug Segment by Type

BF-Derm-1

GDC-0853

GSK-2646264

Bilastine

Others

Chronic Urticaria Or Hives Drug Segment by Application

Clinic

Hospital

Others

Chronic Urticaria Or Hives Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chronic Urticaria Or Hives Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chronic Urticaria Or Hives Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chronic Urticaria Or Hives Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Chronic Urticaria Or Hives Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Chronic Urticaria Or Hives Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Chronic Urticaria Or Hives Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Chronic Urticaria Or Hives Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Chronic Urticaria Or Hives Drug Industry Trends Table 2. Chronic Urticaria Or Hives Drug Industry Drivers Table 3. Chronic Urticaria Or Hives Drug Industry Opportunities and Challenges Table 4. Chronic Urticaria Or Hives Drug Industry Restraints Table 5. Global Chronic Urticaria Or Hives Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Chronic Urticaria Or Hives Drug Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Chronic Urticaria Or Hives Drug Sales Market Share by Manufacturers Table 9. Global Chronic Urticaria Or Hives Drug Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Chronic Urticaria Or Hives Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Chronic Urticaria Or Hives Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Chronic Urticaria Or Hives Drug Manufacturers, Product Type & Application Table 13. Global Chronic Urticaria Or Hives Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Chronic Urticaria Or Hives Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of BF-Derm-1 Table 17. Major Manufacturers of GDC-0853 Table 18. Major Manufacturers of GSK-2646264 Table 19. Major Manufacturers of Bilastine Table 20. Major Manufacturers of Others Table 21. Global Chronic Urticaria Or Hives Drug Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 22. Global Chronic Urticaria Or Hives Drug Sales by Type (2021-2026) & (W Units) Table 23. Global Chronic Urticaria Or Hives Drug Sales by Type (2027-2032) & (W Units) Table 24. Global Chronic Urticaria Or Hives Drug Sales Market Share by Type (2021-2026) Table 25. Global Chronic Urticaria Or Hives Drug Sales Market Share by Type (2027-2032) Table 26. Global Chronic Urticaria Or Hives Drug Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 27. Global Chronic Urticaria Or Hives Drug Revenue by Type (2021-2026) & (W Units) Table 28. Global Chronic Urticaria Or Hives Drug Revenue by Type (2027-2032) & (W Units) Table 29. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Type (2021-2026) Table 30. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Clinic Table 32. Major Manufacturers of Hospital Table 33. Major Manufacturers of Others Table 34. Global Chronic Urticaria Or Hives Drug Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 35. Global Chronic Urticaria Or Hives Drug Sales by Application (2021-2026) & (W Units) Table 36. Global Chronic Urticaria Or Hives Drug Sales by Application (2027-2032) & (W Units) Table 37. Global Chronic Urticaria Or Hives Drug Sales Market Share by Application (2021-2026) Table 38. Global Chronic Urticaria Or Hives Drug Sales Market Share by Application (2027-2032) Table 39. Global Chronic Urticaria Or Hives Drug Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 40. Global Chronic Urticaria Or Hives Drug Revenue by Application (2021-2026) & (W Units) Table 41. Global Chronic Urticaria Or Hives Drug Revenue by Application (2027-2032) & (W Units) Table 42. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Application (2021-2026) Table 43. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Application (2027-2032) Table 44. Global Chronic Urticaria Or Hives Drug Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 45. Global Chronic Urticaria Or Hives Drug Sales by Region (2021-2026) & (W Units) Table 46. Global Chronic Urticaria Or Hives Drug Sales Market Share by Region (2021-2026) Table 47. Global Chronic Urticaria Or Hives Drug Sales Forecasted by Region (2027-2032) & (W Units) Table 48. Global Chronic Urticaria Or Hives Drug Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Chronic Urticaria Or Hives Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 50. North America Chronic Urticaria Or Hives Drug Sales by Country (2021-2026) & (W Units) Table 51. North America Chronic Urticaria Or Hives Drug Sales by Country (2027-2032) & (W Units) Table 52. Europe Chronic Urticaria Or Hives Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 53. Europe Chronic Urticaria Or Hives Drug Sales by Country (2021-2026) & (W Units) Table 54. Europe Chronic Urticaria Or Hives Drug Sales by Country (2027-2032) & (W Units) Table 55. Asia Pacific Chronic Urticaria Or Hives Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 56. Asia Pacific Chronic Urticaria Or Hives Drug Sales by Country (2021-2026) & (W Units) Table 57. Asia Pacific Chronic Urticaria Or Hives Drug Sales by Country (2027-2032) & (W Units) Table 58. South America, Middle East and Africa Chronic Urticaria Or Hives Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 59. South America, Middle East and Africa Chronic Urticaria Or Hives Drug Sales by Country (2021-2026) & (W Units) Table 60. South America, Middle East and Africa Chronic Urticaria Or Hives Drug Sales by Country (2027-2032) & (W Units) Table 61. Global Chronic Urticaria Or Hives Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Chronic Urticaria Or Hives Drug Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Chronic Urticaria Or Hives Drug Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Region (2021-2026) Table 65. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Region (2027-2032) Table 66. Novartis AG Company Information Table 67. Novartis AG Business Overview Table 68. Novartis AG Chronic Urticaria Or Hives Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Novartis AG Chronic Urticaria Or Hives Drug Product Portfolio Table 70. Novartis AG Recent Development Table 71. Merck & Co., Inc. Company Information Table 72. Merck & Co., Inc. Business Overview Table 73. Merck & Co., Inc. Chronic Urticaria Or Hives Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Merck & Co., Inc. Chronic Urticaria Or Hives Drug Product Portfolio Table 75. Merck & Co., Inc. Recent Development Table 76. AstraZeneca Plc Company Information Table 77. AstraZeneca Plc Business Overview Table 78. AstraZeneca Plc Chronic Urticaria Or Hives Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. AstraZeneca Plc Chronic Urticaria Or Hives Drug Product Portfolio Table 80. AstraZeneca Plc Recent Development Table 81. Panacea Biotec Limited Company Information Table 82. Panacea Biotec Limited Business Overview Table 83. Panacea Biotec Limited Chronic Urticaria Or Hives Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Panacea Biotec Limited Chronic Urticaria Or Hives Drug Product Portfolio Table 85. Panacea Biotec Limited Recent Development Table 86. Mycenax Biotech Inc. Company Information Table 87. Mycenax Biotech Inc. Business Overview Table 88. Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Product Portfolio Table 90. Mycenax Biotech Inc. Recent Development Table 91. Mabtech Limited Company Information Table 92. Mabtech Limited Business Overview Table 93. Mabtech Limited Chronic Urticaria Or Hives Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Mabtech Limited Chronic Urticaria Or Hives Drug Product Portfolio Table 95. Mabtech Limited Recent Development Table 96. J Uriach Y Compania, S.A. Company Information Table 97. J Uriach Y Compania, S.A. Business Overview Table 98. J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Product Portfolio Table 100. J Uriach Y Compania, S.A. Recent Development Table 101. GlaxoSmithKline Plc Company Information Table 102. GlaxoSmithKline Plc Business Overview Table 103. GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Product Portfolio Table 105. GlaxoSmithKline Plc Recent Development Table 106. Genentech, Inc. Company Information Table 107. Genentech, Inc. Business Overview Table 108. Genentech, Inc. Chronic Urticaria Or Hives Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Genentech, Inc. Chronic Urticaria Or Hives Drug Product Portfolio Table 110. Genentech, Inc. Recent Development Table 111. Faes Farma, SA Company Information Table 112. Faes Farma, SA Business Overview Table 113. Faes Farma, SA Chronic Urticaria Or Hives Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Faes Farma, SA Chronic Urticaria Or Hives Drug Product Portfolio Table 115. Faes Farma, SA Recent Development Table 116. ELORAC, Inc. Company Information Table 117. ELORAC, Inc. Business Overview Table 118. ELORAC, Inc. Chronic Urticaria Or Hives Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. ELORAC, Inc. Chronic Urticaria Or Hives Drug Product Portfolio Table 120. ELORAC, Inc. Recent Development Table 121. Biofrontera AG Company Information Table 122. Biofrontera AG Business Overview Table 123. Biofrontera AG Chronic Urticaria Or Hives Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. Biofrontera AG Chronic Urticaria Or Hives Drug Product Portfolio Table 125. Biofrontera AG Recent Development Table 126. Key Raw Materials Table 127. Raw Materials Key Suppliers Table 128. Chronic Urticaria Or Hives Drug Distributors List Table 129. Chronic Urticaria Or Hives Drug Customers List Table 130. Research Programs/Design for This Report Table 131. Authors List of This Report Table 132. Secondary Sources Table 133. Primary Sources List of Figures Figure 1. Chronic Urticaria Or Hives Drug Product Image Figure 2. Global Chronic Urticaria Or Hives Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chronic Urticaria Or Hives Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Chronic Urticaria Or Hives Drug Sales (2021-2032) & (W Units) Figure 5. Global Chronic Urticaria Or Hives Drug Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Chronic Urticaria Or Hives Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. BF-Derm-1 Image Figure 9. GDC-0853 Image Figure 10. GSK-2646264 Image Figure 11. Bilastine Image Figure 12. Others Image Figure 13. Global Chronic Urticaria Or Hives Drug Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 14. Global Chronic Urticaria Or Hives Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Chronic Urticaria Or Hives Drug Sales Market Share by Type (2021-2032) Figure 16. Global Chronic Urticaria Or Hives Drug Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 17. Global Chronic Urticaria Or Hives Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Type (2021-2032) Figure 19. Clinic Image Figure 20. Hospital Image Figure 21. Others Image Figure 22. Global Chronic Urticaria Or Hives Drug Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 23. Global Chronic Urticaria Or Hives Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Chronic Urticaria Or Hives Drug Sales Market Share by Application (2021-2032) Figure 25. Global Chronic Urticaria Or Hives Drug Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 26. Global Chronic Urticaria Or Hives Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Application (2021-2032) Figure 28. North America Chronic Urticaria Or Hives Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 29. North America Chronic Urticaria Or Hives Drug Sales Market Share by Country (2021-2032) Figure 30. U.S. Chronic Urticaria Or Hives Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 31. Canada Chronic Urticaria Or Hives Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 32. Mexico Chronic Urticaria Or Hives Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 33. Europe Chronic Urticaria Or Hives Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 34. Europe Chronic Urticaria Or Hives Drug Sales Market Share by Country (2021-2032) Figure 35. Germany Chronic Urticaria Or Hives Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 36. France Chronic Urticaria Or Hives Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 37. U.K. Chronic Urticaria Or Hives Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 38. Italy Chronic Urticaria Or Hives Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 39. Netherlands Chronic Urticaria Or Hives Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 40. Asia Pacific Chronic Urticaria Or Hives Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 41. Asia Pacific Chronic Urticaria Or Hives Drug Sales Market Share by Country (2021-2032) Figure 42. China Chronic Urticaria Or Hives Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 43. Japan Chronic Urticaria Or Hives Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 44. South Korea Chronic Urticaria Or Hives Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 45. Southeast Asia Chronic Urticaria Or Hives Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 46. India Chronic Urticaria Or Hives Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 47. Australia Chronic Urticaria Or Hives Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 48. South America, Middle East and Africa Chronic Urticaria Or Hives Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 49. South America, Middle East and Africa Chronic Urticaria Or Hives Drug Sales Market Share by Country (2021-2032) Figure 50. Brazil Chronic Urticaria Or Hives Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 51. South Africa Chronic Urticaria Or Hives Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 52. Saudi Arabia Chronic Urticaria Or Hives Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 53. Turkey Chronic Urticaria Or Hives Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 54. Argentina Chronic Urticaria Or Hives Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 55. UAE Chronic Urticaria Or Hives Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 56. Egypt Chronic Urticaria Or Hives Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 57. Chile Chronic Urticaria Or Hives Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 58. Global Chronic Urticaria Or Hives Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Chronic Urticaria Or Hives Drug Revenue (2021-2032) & (US$ Million) Figure 61. North America Chronic Urticaria Or Hives Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Chronic Urticaria Or Hives Drug Revenue (2021-2032) & (US$ Million) Figure 63. Europe Chronic Urticaria Or Hives Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Chronic Urticaria Or Hives Drug Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Chronic Urticaria Or Hives Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Chronic Urticaria Or Hives Drug Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Chronic Urticaria Or Hives Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Chronic Urticaria Or Hives Drug Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Chronic Urticaria Or Hives Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • BF-Derm-1
  • GDC-0853
  • GSK-2646264
  • Bilastine
  • Others
Applications
  • Clinic
  • Hospital
  • Others
Companies covered
  • Novartis AG
  • Merck & Co., Inc.
  • AstraZeneca Plc
  • Panacea Biotec Limited
  • Mycenax Biotech Inc.
  • Mabtech Limited
  • J Uriach Y Compania, S.A.
  • GlaxoSmithKline Plc
  • Genentech, Inc.
  • Faes Farma, SA
  • ELORAC, Inc.
  • Biofrontera AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Chronic Urticaria Or Hives Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Chronic Urticaria Or Hives Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Chronic Urticaria Or Hives Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Chronic Urticaria Or Hives Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Chronic Urticaria Or Hives Drug Market Dynamics
  1. 2.1 Chronic Urticaria Or Hives Drug Industry Trends
  2. 2.2 Chronic Urticaria Or Hives Drug Industry Drivers
  3. 2.3 Chronic Urticaria Or Hives Drug Industry Opportunities and Challenges
  4. 2.4 Chronic Urticaria Or Hives Drug Industry Restraints
3 Chronic Urticaria Or Hives Drug Market by Manufacturers
  1. 3.1 Global Chronic Urticaria Or Hives Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Chronic Urticaria Or Hives Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Chronic Urticaria Or Hives Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Chronic Urticaria Or Hives Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Chronic Urticaria Or Hives Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Chronic Urticaria Or Hives Drug Manufacturers, Product Type & Application
  7. 3.7 Global Chronic Urticaria Or Hives Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Chronic Urticaria Or Hives Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Chronic Urticaria Or Hives Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Chronic Urticaria Or Hives Drug Tier 1, Tier 2, and Tier 3
4 Chronic Urticaria Or Hives Drug Market by Type
  1. 4.1 Chronic Urticaria Or Hives Drug Type Introduction
  2. 4.1.1 BF-Derm-1
  3. 4.1.2 GDC-0853
  4. 4.1.3 GSK-2646264
  5. 4.1.4 Bilastine
  6. 4.1.5 Others
  7. 4.2 Global Chronic Urticaria Or Hives Drug Sales by Type
  8. 4.2.1 Global Chronic Urticaria Or Hives Drug Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Chronic Urticaria Or Hives Drug Sales by Type (2021-2032)
  10. 4.2.3 Global Chronic Urticaria Or Hives Drug Sales Market Share by Type (2021-2032)
  11. 4.3 Global Chronic Urticaria Or Hives Drug Revenue by Type
  12. 4.3.1 Global Chronic Urticaria Or Hives Drug Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Chronic Urticaria Or Hives Drug Revenue by Type (2021-2032)
  14. 4.3.3 Global Chronic Urticaria Or Hives Drug Revenue Market Share by Type (2021-2032)
5 Chronic Urticaria Or Hives Drug Market by Application
  1. 5.1 Chronic Urticaria Or Hives Drug Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Others
  5. 5.2 Global Chronic Urticaria Or Hives Drug Sales by Application
  6. 5.2.1 Global Chronic Urticaria Or Hives Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Chronic Urticaria Or Hives Drug Sales by Application (2021-2032)
  8. 5.2.3 Global Chronic Urticaria Or Hives Drug Sales Market Share by Application (2021-2032)
  9. 5.3 Global Chronic Urticaria Or Hives Drug Revenue by Application
  10. 5.3.1 Global Chronic Urticaria Or Hives Drug Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Chronic Urticaria Or Hives Drug Revenue by Application (2021-2032)
  12. 5.3.3 Global Chronic Urticaria Or Hives Drug Revenue Market Share by Application (2021-2032)
6 Global Chronic Urticaria Or Hives Drug Sales by Region
  1. 6.1 Global Chronic Urticaria Or Hives Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Chronic Urticaria Or Hives Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Chronic Urticaria Or Hives Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Chronic Urticaria Or Hives Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Chronic Urticaria Or Hives Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Chronic Urticaria Or Hives Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Chronic Urticaria Or Hives Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Chronic Urticaria Or Hives Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Chronic Urticaria Or Hives Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Chronic Urticaria Or Hives Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Chronic Urticaria Or Hives Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Chronic Urticaria Or Hives Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Chronic Urticaria Or Hives Drug Revenue by Region
  1. 7.1 Global Chronic Urticaria Or Hives Drug Revenue by Region
  2. 7.1.1 Global Chronic Urticaria Or Hives Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Chronic Urticaria Or Hives Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Chronic Urticaria Or Hives Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Chronic Urticaria Or Hives Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Chronic Urticaria Or Hives Drug Revenue (2021-2032)
  8. 7.2.2 North America Chronic Urticaria Or Hives Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Chronic Urticaria Or Hives Drug Revenue (2021-2032)
  11. 7.3.2 Europe Chronic Urticaria Or Hives Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Chronic Urticaria Or Hives Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Chronic Urticaria Or Hives Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Chronic Urticaria Or Hives Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Chronic Urticaria Or Hives Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis AG
  2. 8.1.1 Novartis AG Company Information
  3. 8.1.2 Novartis AG Business Overview
  4. 8.1.3 Novartis AG Chronic Urticaria Or Hives Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Novartis AG Chronic Urticaria Or Hives Drug Product Portfolio
  6. 8.1.5 Novartis AG Recent Developments
  7. 8.2 Merck & Co., Inc.
  8. 8.2.1 Merck & Co., Inc. Company Information
  9. 8.2.2 Merck & Co., Inc. Business Overview
  10. 8.2.3 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Product Portfolio
  12. 8.2.5 Merck & Co., Inc. Recent Developments
  13. 8.3 AstraZeneca Plc
  14. 8.3.1 AstraZeneca Plc Company Information
  15. 8.3.2 AstraZeneca Plc Business Overview
  16. 8.3.3 AstraZeneca Plc Chronic Urticaria Or Hives Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 AstraZeneca Plc Chronic Urticaria Or Hives Drug Product Portfolio
  18. 8.3.5 AstraZeneca Plc Recent Developments
  19. 8.4 Panacea Biotec Limited
  20. 8.4.1 Panacea Biotec Limited Company Information
  21. 8.4.2 Panacea Biotec Limited Business Overview
  22. 8.4.3 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Product Portfolio
  24. 8.4.5 Panacea Biotec Limited Recent Developments
  25. 8.5 Mycenax Biotech Inc.
  26. 8.5.1 Mycenax Biotech Inc. Company Information
  27. 8.5.2 Mycenax Biotech Inc. Business Overview
  28. 8.5.3 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Product Portfolio
  30. 8.5.5 Mycenax Biotech Inc. Recent Developments
  31. 8.6 Mabtech Limited
  32. 8.6.1 Mabtech Limited Company Information
  33. 8.6.2 Mabtech Limited Business Overview
  34. 8.6.3 Mabtech Limited Chronic Urticaria Or Hives Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Mabtech Limited Chronic Urticaria Or Hives Drug Product Portfolio
  36. 8.6.5 Mabtech Limited Recent Developments
  37. 8.7 J Uriach Y Compania, S.A.
  38. 8.7.1 J Uriach Y Compania, S.A. Company Information
  39. 8.7.2 J Uriach Y Compania, S.A. Business Overview
  40. 8.7.3 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Product Portfolio
  42. 8.7.5 J Uriach Y Compania, S.A. Recent Developments
  43. 8.8 GlaxoSmithKline Plc
  44. 8.8.1 GlaxoSmithKline Plc Company Information
  45. 8.8.2 GlaxoSmithKline Plc Business Overview
  46. 8.8.3 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Product Portfolio
  48. 8.8.5 GlaxoSmithKline Plc Recent Developments
  49. 8.9 Genentech, Inc.
  50. 8.9.1 Genentech, Inc. Company Information
  51. 8.9.2 Genentech, Inc. Business Overview
  52. 8.9.3 Genentech, Inc. Chronic Urticaria Or Hives Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Genentech, Inc. Chronic Urticaria Or Hives Drug Product Portfolio
  54. 8.9.5 Genentech, Inc. Recent Developments
  55. 8.10 Faes Farma, SA
  56. 8.10.1 Faes Farma, SA Company Information
  57. 8.10.2 Faes Farma, SA Business Overview
  58. 8.10.3 Faes Farma, SA Chronic Urticaria Or Hives Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Faes Farma, SA Chronic Urticaria Or Hives Drug Product Portfolio
  60. 8.10.5 Faes Farma, SA Recent Developments
  61. 8.11 ELORAC, Inc.
  62. 8.11.1 ELORAC, Inc. Company Information
  63. 8.11.2 ELORAC, Inc. Business Overview
  64. 8.11.3 ELORAC, Inc. Chronic Urticaria Or Hives Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 ELORAC, Inc. Chronic Urticaria Or Hives Drug Product Portfolio
  66. 8.11.5 ELORAC, Inc. Recent Developments
  67. 8.12 Biofrontera AG
  68. 8.12.1 Biofrontera AG Company Information
  69. 8.12.2 Biofrontera AG Business Overview
  70. 8.12.3 Biofrontera AG Chronic Urticaria Or Hives Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Biofrontera AG Chronic Urticaria Or Hives Drug Product Portfolio
  72. 8.12.5 Biofrontera AG Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Chronic Urticaria Or Hives Drug Value Chain Analysis
  2. 9.1.1 Chronic Urticaria Or Hives Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Chronic Urticaria Or Hives Drug Production Mode & Process
  6. 9.2 Chronic Urticaria Or Hives Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Chronic Urticaria Or Hives Drug Distributors
  9. 9.2.3 Chronic Urticaria Or Hives Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst